|Day Low/High||3.66 / 3.91|
|52 Wk Low/High||3.40 / 11.00|
Seaport Global says it expects pricing and margins to 'drop considerably' in the Canadian cannabis market.
Our views on CPI Aerostructures, Encana Corp. and Aurora Cannabis.
`[The consensus] may be expecting too much sequentially from names in a market where growth is not significant (yet), some capacity is set aside for extraction, and costs are increasing on derivatives prep,' analyst Owen Bennett wrote.
This group appears oversold and downgrades of the big cannabis names may trigger a "buy the bad news" reaction.
A class-action lawsuit against Canadian cannabis operator Sundial Growers hurt the sector Monday, but stocks turned around in afternoon trading Tuesday.
Dissolve Strips ™ Now Available to Aurora's Canadian Medical Patients NYSE | TSX: ACB OTC: CTTH EDMONTON and HAMILTON, ON, Oct.
TSX: ACB | NYSE: ACB Cultivation Leadership Further Strengthened as Global Facilities Achieve Significant Milestones Global Market Expansion Continues in Medical Cannabis and Hemp Markets Network of Strategic Partners Continue to Demonstrate Value on...
`We are already beginning to see the cracks in Canada: Pricing is down and consumption per federal license is contracting.'
The government agency says 77% of infected patients were using THC-containing products.
GW Pharma stock does not look healthy. Here are the must-know levels on the cannabis company now.
TSX: ACB | NYSE: ACB EDMONTON, Sept. 20, 2019 /PRNewswire/ - Aurora Cannabis Inc.
MKM Partners initiates coverage on seven different Canadian cannabis companies.
Aurora Cannabis falls Monday after an analyst from Stifel Nicolaus cuts his rating on the medical cannabis products company to sell from hold and slashes his price target.
MedMen was the bear call in Cowen's report.
The Dow finished up for the seventh straight day Thursday despite conflicting signals on an interim deal with China that would delay tariffs, while the European Central Bank cut its main deposit rate.
Aurora Cannabis is getting crushed after disappointing earnings. Are new lows in store and can the bulls muster a rally in ACB stock?
Aurora Cannabis shares were indicated sharply lower in pre-market trading Thursday after the Canadian marijuana group posted weaker-than-expected fourth quarter revenues as cannabis prices continue to decline following last year's move to legalize the sale of recreational cannabis.
Canadian cannabis company misses its own net revenue guidance, provides no per-share figures.
Generates Net Revenue of $98.9 Million, Up 52% From Prior Quarter Cannabis Net Revenue Increases 61% to $94.
Aurora Cannabis is scheduled to report its fourth quarter results after the bell Wednesday.
A market repricing...which are the 'true' growth stocks now?
U.S. stock futures rose slightly after China says it will allow some exemptions to additional tariffs on U.S. imports; Apple bets big on camera improvements in its new iPhone 11; GameStop and Dave & Buster's sink on weak guidance; GE to give up majority control of Baker Hughes.
Aurora Cannabis revenue expected to rise 452.2% to $81.7 million.
NYSE | TSX : ACB EDMONTON, Sept. 9, 2019 /PRNewswire/ - Aurora Cannabis Inc.
U.S. stock futures rise as investors bet on near-term stimulus from the world's biggest central banks to offset slowing trade and manufacturing activity; Apple is expected on Tuesday to unveil updated iPhone models and a host of new products and services; WeWork's parent company reportedly is considering a further cut to its valuation; Boeing suspends testing of 777X aircraft.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.